Entrada Therapeutics Announces Recipients of Third Annual DREAMS Grant Program
1. TRDA awarded $50,000 grants to two organizations supporting Duchenne community. 2. Grants announced ahead of World Duchenne Awareness Day on September 7. 3. Funding focuses on inclusion and support for underserved Duchenne patients. 4. Commitment to transformative change emphasized by CEO Dipal Doshi. 5. Entrada's ongoing mission includes patient engagement beyond therapeutic development.